In Design of Adeno-Associated Virus (AAV) for Gene Therapy, Dr. Patrick Ellison Sewell, Jr., M.D., translates over thirty years of pioneering research and clinical innovation into an essential resource for understanding and applying gene therapy through AAV vectors. Recognized internationally for his groundbreaking contributions in interventional oncology, stem cell therapies, and clinical gene therapy, Dr. Sewell now presents a detailed and practical guide for researchers, clinicians, and biotechnology professionals aiming to harness the transformative potential of gene-based medicine. This comprehensive guide clearly and methodically addresses each aspect crucial to effective AAV vector development—from selecting optimal serotypes and designing therapeutic plasmids to ensuring rigorous quality control and regulatory compliance. With an emphasis on practical techniques, Dr. Sewell navigates readers through the intricacies of vector construction, promoter selection, gene optimization, and advanced applications, including gene editing technologies and targeted gene expression. You will gain invaluable insights into: • The strategic selection of AAV serotypes for tissue-specific gene delivery. • Advanced engineering methods to enhance efficacy and minimize immune responses. • Protocols for manufacturing and scaling vectors from laboratory research to clinical-grade production. • Cutting-edge innovations and future directions in gene therapies targeting cancer, neurological disorders, and aging. • Whether you’re a seasoned clinician, researcher, or industry professional, this book serves as your comprehensive guide to mastering the complexities and unlocking the therapeutic potential of AAV vectors. Dr. Patrick Ellison Sewell, Jr., M.D., is a globally acclaimed physician and innovator renowned for his transformative impact on cancer treatment and regenerative medicine. After completing extensive training at esteemed institutions including Harvard and Stanford, he revolutionized interventional oncology with the world’s first image-guided percutaneous tumor cryo-ablation and lung tumor ablation procedures. Dr. Sewell has consistently expanded the boundaries of medicine, from pioneering radiation-reduction technologies to designing remote surgical robotics with NASA. Today, Dr. Sewell leads international efforts in clinical gene therapy, having personally administered treatments to over 120 patients. As the founder of multiple biotech companies and a leader at TriplHelix, his work continues to set new standards in patient care, precision medicine, and regenerative therapies.